Acetylation of Androgen Receptor Enhances Coactivator Binding and Promotes Prostate Cancer Cell Growth

Molecular and Cellular Biology

Volumn 23, Issue 23, 2003, Pages 8563-8575

  Fu, Maofu ^a   Rao, Mahadev ^a   Wang, Chenguang ^a   Sakamaki, Toshiyuki ^a   Wang, Jian ^a   Di Vizio, Dolores ^a   Zhang, Xueping ^a   Albanese, Chris ^a   Balk, Steven ^b   Chang, Chawnshang ^c   Fan, Saijun ^a   Rosen, Eliot ^a   Palvimo, Jorma J ^d   Jänne, Olli A ^d   Muratoglu, Selen ^e   Avantaggiati, Maria Laura ^e   Pestell, Richard G ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d UNIVERSITY OF HELSINKI   (Finland)

^e GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; DNA BINDING PROTEIN; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; PROTEIN P300; SMAD3 PROTEIN;

ACETYLATION; AGAR MEDIUM; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; GENE TARGETING; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; SUBSTITUTION REACTION; TRANSCRIPTION REGULATION;

ACETYLATION; AMINO ACID SUBSTITUTION; ANIMALS; APOPTOSIS; BINDING SITES; CELL DIVISION; CELL LINE, TUMOR; DIHYDROTESTOSTERONE; E1A-ASSOCIATED P300 PROTEIN; HISTONE DEACETYLASES; HUMANS; LIGANDS; MALE; MICE; MICE, NUDE; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TRANS-ACTIVATORS;

MUS MUSCULUS;

EID: 0242637385     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.23.8563-8575.2003     Document Type: Article

References (47)

1. Abate-Shen, C., and M. M. Shen. 2000. Molecular genetics of prostate cancer. Genes Dev. 14:2410-2434.
2. Abreu-Martin, M. T., A. Chari, A. A. Palladino, N. A. Craft, and C. L. Sawyers. 1999. Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancer. Mol. Cell. Biol. 19:5143-5154.
3. Alland, L., R. Muhle, H. J. Hou, J. Potes, L. Chin, N. Schreiber-Agus, and R. A. DePinho. 1997. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387:49-55.
4. Chen, D., H. Ma, H. Hong, S. S. Koh, S. M. Huang, B. T. Schurter, D. W. Aswad, and M. R. Stallcup. 1999. Regulation of transcription by a protein methyltransferase. Science 284:2174-2177.
5. Chen, J. D., and R. M. Evans. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457.
6. Costanzo, A., P. Merlo, N. Pediconi, M. Fulco, V. Sartorelli, P. A. Cole, G. Fontemaggi, M. Fanciulli, L. Schiltz, G. Blandino, C. Balsano, and M. Levrero. 2002. DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes. Mol. Cell. 9:175-186.
7. Fu, M., C. Wang, A. T. Reutens, J. Wang, R. H. Angeletti, L. Siconolfi-Baez, V. Ogryzko, M. L. Avantaggiati, and R. G. Pestell. 2000. p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. J. Biol. Chem. 275:20853-20860.
8. Fu, M., C. Wang, J. Wang, X. Zhang, T. Sakamaki, Y. G. Yeung, C. Chang, T. Hopp, S. A. Fuqua, E. Jaffray, R. T. Hay, J. J. Palvimo, O. A. Janne, and R. G. Pestell. 2002. Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function. Mol. Cell Biol. 22:3373-3388.
9. Gao, J., and J. T. Isaacs. 1998. Development of an androgen receptor-null model for identifying the initiation site for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC-82 human prostate cancer cells. Cancer Res. 58:3299-3306.
10. Gaughan, L., I. R. Logan, S. Cook, D. E. Neal, and C. N. Robson. 2002. Tip60 and Histone Deacetylase 1 Regulate Androgen Receptor Activity through Changes to the Acetylation Status of the Receptor. J. Biol. Chem. 277:25904-25913.
11. Glass, C. K., and M. G. Rosenfeld. 2000. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14:121-141.
12. Harrod, R., J. Nacsa, C. Van Lint, J. Hansen, T. Karpova, J. McNally, and G. Franchini. 2002. Human immunodeficiency virus type-1 Tat/Co-activator acetyltransferase interactions inhibit p53K320-acetylation and p53-responsive transcription. J. Biol. Chem. 278:12310-12318.
13. Hayes, S., M. Zarnegar, M. Sharma, F. Yang, D. M. Peehl, P. ten Dijke, and Z. Sun. 2001. SMAD3 represses androgen receptor-mediated transcription. Cancer Res. 61:2112-2118.
14. Hayes, S. A., M. Zarnegar, M. Sharma, F. Yang, D. M. Peehl, P. ten Dijke, and Z. Sun. 2001. SMAD3 represses androgen receptor-mediated transcription. Cancer Res. 61:2112-2118.
15. Heinzel, T., R. M. Lavinsky, T. M. Mullen, M. Soderstrom, C. D. Laherty, J. Torchia, W. M. Yang, G. Brard, S. D. Ngo, J. R. Davie, E. Seto, R. N. Eisenman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1997. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387:43-48.
16. Heisler, L. E., A. Evangelou, A. M. Lew, J. Trachtenberg, H. P. Elsholtz, and T. J. Brown. 1997. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor. Mol. Cell. Endocrinol. 126:59-73.
17. Higashimoto, Y., S. Salto, X. H. Tong, A. Hong, K. Sakaguchi, E. Appella, and C. W. Anderson. 2000. Human p53 is phosphorylated on serines 6 and 9 in response to DNA damage-inducing agents. J. Biol. Chem. 275:23199-23203.
18. Horlein, A. J., A. M. Naar, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamei, M. Soderstrom, C. K. Glass, et al. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404.
19. Hu, X., Y. Li, and M. A. Lazar. 2001. Determinants of CoRNR-dependent repression complex assembly on nuclear hormone receptors. Mol. Cell. Biol. 21:1747-1758.
20. Hunter, T. 1997. Oncoprotein networks. Cell. 88:333-346.
21. Jacobson, R. H., A. G. Ladurner, D. S. King, and R. Tjian. 2000. Structure and function of a human TAFII250 double bromodomain module. Science 288:1422-1425.
22. Janssen, T., R. Kiss, R. Dedecker, M. Petein, J. L. Pasteels, and C. Schulman. 1995. Influence of dihydrotestosterone, epidermal growth factor, and basic fibroblast growth factor on the cell kinetics of the PC3, DU145, and LNCaP prostatic cancer cell lines: relationship with DNA ploidy level. Prostate 27:277-286.
23. Karin, M., and T. Hunter. 1995. Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr. Biol. 5:747-757.
24. Kouzarides, T. 2000. Acetylation: a regulatory modification to rival phosphorylation. EMBO J. 19:1176-1179.
25. Lee, Y. F., W. J. Lin, J. Huang, E. M. Messing, F. L. Chan, G. Wilding, and C. Chang. 2002. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells. Cancer Res. 62:6039-6044.
26. Lin, H. K., S. Yeh, H. Y. Kang, and C. Chang. 2001. Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor. Proc. Natl. Acad. Sci. 98:7200-7205.
27. Liu, L., D. M. Scolnick, R. C. Trievel, H. B. Zhang, R. Marmorstein, T. D. Halazonetis, and S. L. Berger. 1999. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol. Cell. Biol. 19:1202-1209.
28. Mauser, A., S. Saito, E. Appella, C. W. Anderson, W. T. Seaman, and S. Kenney. 2002. The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms. J. Virol. 76:12503-12512.
29. McKenna, N. J., R. B. Lanz, and B. W. O'Malley. 1999. Nuclear receptor coregulators: cellular and molecular biology. Endocrinol. Rev. 20:321-344.
30. Nagy, L., H. Y. Kao, D. Chakravarti, R. J. Lin, C. A. Hassig, D. E. Ayer, S. L. Schreiber, and R. M. Evans. 1997. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A and histone deacetylase. Cell. 89:373-380.
31. Ogryzko, V. V., R. L. Schiltz, V. Russanova, B. H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 87:953-959.
32. Perissi, V., L. M. Staszewski, E. M. McInerney, R. Kurokawa, A. Krones, D. W. Rose, M. H. Lambert, M. V. Milburn, C. K. Glass, and M. G. Rosenfeld. 1999. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev. 13:3198-3208.
33. Polesskaya, A., I. Naguibneva, A. Duquet, E. Bengal, P. Robin, and A. Harel-Bellan. 2001. Interaction between acetylated MyoD and the bromo-domain of CBP and/or p300. Mol. Cell. Biol. 21:5312-5320.
34. Poukka, H., P. Aarnisalo, U. Karvonen, J. J. Palvimo, and O. A. Janne. 1999. Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription. J. Biol. Chem. 274:19441-19446.
35. Prives, C., and J. L. Manley. 2001. Why is p53 acetylated? Cell. 107:815-818.
36. Reutens, A. T., M. Fu, C. Wang, C. Albanese, M. J. McPhaul, Z. Sun, S. P. Balk, O. A. Janne, J. J. Palvimo, and R. G. Pestell. 2001. Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner. Mol. Endocrinol. 15:797-811.
37. Sterner, D. E., and S. L. Berger. 2000. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64:435-459.
38. Struhl, K. 1998. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12:599-606.
39. Tan, J., Y. Sharief, K. G. Hamil, C. W. Gregory, D. Y. Zang, M. Sar, P. H. Gumerlock, R. W. DeVere White, T. G. Pretlow, S. E. Harris, E. M. Wilson, J. L. Mohler, and F. S. French. 1997. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells. Mol. Endocrinol. 11:450-459.
40. Taplin, M. E., G. J. Bubley, Y. J. Ko, E. J. Small, M. Upton, B. Rajeshkumar, and S. P. Balk. 1999. Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist. Cancer Res. 59:2511-2515.
41. Taplin, M. E., G. J. Bubley, T. D. Shuster, M. E. Frantz, A. E. Spooner, G. K. Ogata, H. N. Keer, and S. P. Balk. 1995. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N. Engl. J. Med. 332:1393-1398.
42. Torchia, J., C. Glass, and M. G. Rosenfeld. 1998. Co-activators and co-repressors in the integration of transcriptional responses. Curr. Opin. Cell Biol. 10:373-383.
43. Vendola, K. A., J. Zhou, O. O. Adesanya, S. J. Weil, and C. A. Bondy. 1998. Androgens stimulate early stages of follicular growth in the primate ovary. J. Clin. Investig. 101:2622-2629.
44. Vilenchik, M., A. J. Raffo, L. Benimetskay, D. Shames, and C. A. Stein. 2002. Antisense RNA down-regulation of bcl-xL expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents. Cancer Res. 62:2175-2183.
45. Wang, C., M. Fu, S. Mani, S. Wadler, A. M. Senderowicz, and R. G. Pestell. 2001. Histone acetylation and the cell-cycle in cancer. Front. Biosci. 6:D610-D629.
46. Ye, D., J. Mendelsohn, and Z. Fan. 1999. Androgen and epidermal growth factor down-regulate cyclin-dependent kinase inhibitor p27Kip1 and co-stimulate proliferation of MDA PCa 2a and MDA PCa 2b prostate cancer cells. Clin. Cancer Res. 5:2171-2177.
47. Yuan, S., J. Trachtenberg, G. B. Mills, T. J. Brown, F. Xu, and A. Keating. 1993. Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA. Cancer Res. 53:1304-1311.